Tuesday, September 28, 2021

Experimental drug development approach points to better targeted therapies for treatment-resistant leukemia

New research shows why some drugs in clinical trials for treating a form of acute myeloid leukemia (AML) often fail and demonstrates a way to restore their effectiveness.

from Top Health News -- ScienceDaily https://ift.tt/3CRiklD

No comments:

Post a Comment

One tiny mutation may explain how bat viruses become human threats

Scientists found that one tiny genetic change can completely alter how a coronavirus behaves in different species. Comparing SARS-CoV-2 with...